COMP <GO>
ROAD vs TMO // NET PROFIT MARGIN
Construction Partners Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ROAD 4
— TMO 11
▲ NET PROFIT MARGIN LEADER: TMO
LAST: $89.80 (-2.08%) • MKT CAP: $5.26B
net-margins
3.60%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
net-margins
15.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ROAD VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ROAD | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 15.60% | 41.00% | -25.40 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.90% | 9.30% | -2.40 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.1x | 30.4x | -10.30 | ROAD | /valuation <GO> |
| Free Cash Flow Yield | 2.91% | 2.40% | +0.51 | ROAD | /fcf-yield <GO> |
| Operating Margin | 8.00% | 17.40% | -9.40 | TMO | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 3.60% | 15.10% | -11.50 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 54.20% | 3.90% | +50.30 | ROAD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.67 | 4.50 | -1.83 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.9 | 59.1 | -6.25 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 0.94 | +0.14 | ROAD | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.4x | 36.3x | +7.10 | TMO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.26B | $262.22B | -$256.96B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ROAD REV | TMO REV | ROAD GROSS % | TMO GROSS % | ROAD FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.81B | $44.56B | 15.6% | 44.0% | $153.4M | $6.29B |
| FY 2024 | $1.82B | $42.88B | 14.2% | 44.0% | $121.1M | $7.27B |
| FY 2023 | $1.56B | $42.86B | 44.0% | 44.0% | $86.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ROAD // BETA 1.08
TMO // BETA 0.94